- Home
- Publications
- Publication Search
- Publication Details
Title
The controversial role of ABC transporters in clinical oncology
Authors
Keywords
-
Journal
Essays in Biochemistry
Volume 50, Issue -, Pages 209-232
Publisher
Portland Press Ltd.
Online
2011-09-07
DOI
10.1042/bse0500209
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Synthesis and evaluation of [11C]XR9576 to assess the function of drug efflux transporters using PET
- (2010) Kazunori Kawamura et al. ANNALS OF NUCLEAR MEDICINE
- Zosuquidar, a novel modulator of P-glycoprotein, does not improve the outcome of older patients with newly diagnosed acute myeloid leukemia: a randomized, placebo-controlled trial of the Eastern Cooperative Oncology Group 3999
- (2010) L. D. Cripe et al. BLOOD
- Assessment of Regional Differences in Tariquidar-Induced P-Glycoprotein Modulation at the Human Blood–Brain Barrier
- (2010) Martin Bauer et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- P-Glycoprotein Function at the Blood-Brain Barrier in Humans Can Be Quantified with the Substrate Radiotracer 11C-N-Desmethyl-Loperamide
- (2010) W. C. Kreisl et al. JOURNAL OF NUCLEAR MEDICINE
- Breast Cancer Resistance Protein and P-glycoprotein Limit Sorafenib Brain Accumulation
- (2010) J. S. Lagas et al. MOLECULAR CANCER THERAPEUTICS
- The influence of P-glycoprotein expression and its inhibitors on the distribution of doxorubicin in breast tumors
- (2009) Krupa J Patel et al. BMC CANCER
- Sequential phase II Southwest Oncology Group studies (S0112 and S0301) of daunorubicin and cytarabine by continuous infusion, without and with ciclosporin, in older patients with previously untreated acute myeloid leukaemia
- (2009) Thomas R. Chauncey et al. BRITISH JOURNAL OF HAEMATOLOGY
- Moderate Increase in Mdr1a/1b Expression Causes In vivo Resistance to Doxorubicin in a Mouse Model for Hereditary Breast Cancer
- (2009) M. Pajic et al. CANCER RESEARCH
- Brain Accumulation of Dasatinib Is Restricted by P-Glycoprotein (ABCB1) and Breast Cancer Resistance Protein (ABCG2) and Can Be Enhanced by Elacridar Treatment
- (2009) J. S. Lagas et al. CLINICAL CANCER RESEARCH
- A Phase I Study of the P-Glycoprotein Antagonist Tariquidar in Combination with Vinorelbine
- (2009) J. Abraham et al. CLINICAL CANCER RESEARCH
- Interaction of ABC Multidrug Transporters with Anticancer Protein Kinase Inhibitors: Substrates and/or Inhibitors?
- (2009) Csilla Ozvegy-Laczka et al. CURRENT CANCER DRUG TARGETS
- Imaging of Cyclosporine Inhibition of P-Glycoprotein Activity Using 11C-Verapamil in the Brain: Studies of Healthy Humans
- (2009) M. Muzi et al. JOURNAL OF NUCLEAR MEDICINE
- Association of expression of MRP1, BCRP, LRP and ERCC1 with outcome of patients with locally advanced non-small cell lung cancer who received neoadjuvant chemotherapy
- (2009) Jian Li et al. LUNG CANCER
- Evaluation of [11C]laniquidar as a tracer of P-glycoprotein: radiosynthesis and biodistribution in rats
- (2009) Gert Luurtsema et al. NUCLEAR MEDICINE AND BIOLOGY
- Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding
- (2009) S. G. Aller et al. SCIENCE
- Inhibition of P-glycoprotein (ABCB1)- and multidrug resistance-associated protein 1 (ABCC1)-mediated transport by the orally administered inhibitor, CBT-1®
- (2008) Robert W. Robey et al. BIOCHEMICAL PHARMACOLOGY
- An Unexpected Synergist Role of P-Glycoprotein and Breast Cancer Resistance Protein on the Central Nervous System Penetration of the Tyrosine Kinase Inhibitor Lapatinib (N- -6-[5-( methyl)-2-furyl]-4-quinazolinamine; GW572016)
- (2008) J. W. Polli et al. DRUG METABOLISM AND DISPOSITION
- Polymorphisms inABCG2,ABCC3andCNT1genes and their possible impact on chemotherapy outcome of lung cancer patients
- (2008) Phillip J. Müller et al. INTERNATIONAL JOURNAL OF CANCER
- A phase I trial of continuous infusion of the multidrug resistance inhibitor zosuquidar with daunorubicin and cytarabine in acute myeloid leukemia
- (2008) Jeffrey E. Lancet et al. LEUKEMIA RESEARCH
- Immunohistochemical expression of BCRP and ERCC1 in biopsy specimen predicts survival in advanced non-small-cell lung cancer treated with cisplatin-based chemotherapy
- (2008) Shuji Ota et al. LUNG CANCER
- Expression of breast cancer resistance protein is associated with a poor clinical outcome in patients with small-cell lung cancer
- (2008) Young Hak Kim et al. LUNG CANCER
- Effect of the ATP-binding cassette drug transporters ABCB1, ABCG2, and ABCC2 on erlotinib hydrochloride (Tarceva) disposition in in vitro and in vivo pharmacokinetic studies employing Bcrp1-/-/Mdr1a/1b-/- (triple-knockout) and wild-type mice
- (2008) S. Marchetti et al. MOLECULAR CANCER THERAPEUTICS
- High sensitivity of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugs
- (2008) S. Rottenberg et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now